Investor Ideas, Trading Ideas and Stocks to Watch

Tuesday, March 24, 2020

Special Edition #AIEye: How #ArtificialIntelligence ( #AI) is Tracking, Modeling and Providing Medical Info #Coronavirus (OTC: $GTCH) (NASDAQ: $NVDA) (NYSE: $IBM) (NASDAQ: $MSFT)

Special Edition #AIEye: How #ArtificialIntelligence ( #AI) is Tracking, Modeling and Providing Medical Info #Coronavirus (OTC: $GTCH) (NASDAQ: $NVDA) (NYSE: $IBM) (NASDAQ: $MSFT)

Point Roberts WA, Vancouver BC – March 24, 2020 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye which looks at how AI is playing a leading role in tracking, modeling and providing general medical information as well as information on the coronavirus, featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

Read this news featuring GTCH in full at https://www.investorideas.com/news/2020/artificial-intelligence/03241AIEye-GTCH-NVDA-IBM-MSFT.asp

Taiwan, one of the countries that got it right according to a recent article by Stanford Health Policy, used AI, big data and analytics to track and manage the disease in combination with proactive testing.

“Taiwan’s government learned from its 2003 SARS experience and established a public health response mechanism for enabling rapid actions for the next crisis.”

ABC news reported, “Audrey Tang, Taiwan's digital minister and the youngest minister without portfolio to hold office, utilized artificial intelligence to harness data and created real-time digital updates to alert citizens of risky areas to avoid and a live map of local supplies of face masks.”

Currently (as of March 22, 2020) Taiwan has 169 cases, 2 deaths and 28 recovered.

The US is now following a similar path, with tech leaders and government turning to AI for solutions, with initiatives including the COVID-19 Open Research Dataset (CORD-19).

Smaller companies like GBT Technologies, Inc. (OTCPINK:GTCH) an emerging technology company focusing on artificial intelligence innovations and chip design was directing research and development resources into healthcare and medicine prior to the pandemic, using the company’s Avant! AI licensed technology (https://www.avant-ai.net) and introducing as “derivative” a new tool - https://www.hmd.care as beta version.

In a previous interview with Investor Ideas, CTO Danny Rittman explained how Avant!, powered by cooperation with Costa Rica developers works: "Our goal is to implement a fundamental part of human intelligence called relational reasoning, which is planned to enable Avant! to acquire expertise on its own by understanding object's relations. Avant! will include an advanced artificial neural network (ANN) capable of pattern recognition and reasoning about those patterns which is very similar to the human brain. Rather than operating on pre-set rules, the system will learn image's patterns by tweaking the relations between objects, analyzing connections, and building hypotheses about how they relate to each other. This capability will be used for Avant! imaging system for upcoming implementation in the medical field. We are creating an interactive and intuitive intelligent system that performs complex computation over discrete entities and the relations between them. Our goal is to provide Avant! a broad range of advantages and capabilities when it comes to intelligent imaging, especially in the medical domain."

Building on its healthcare applications, a new development from the team at Costa Rica is the launch of Hippocrates – its new AI-based medical advisor (https://www.hmd.care). Hippocrates health system is an AI-based medical advisor. Users may provide symptoms, ask medical questions and describe conditions in order to get diagnosis advice including known medications and treatments. This means a reliable, simple and fast medical assistance experiences for people around the world. It provides the essential capabilities necessary to advise patients about medical symptoms and conditions based on data and analytics taken from The National Center for Biotechnology, CDC and other accredited resources. The system is now in testing phase and has been trained to support basic health information. The team will evaluate the system for the next few months, targeting it to ultimately becoming an expert in a specific area, for example, respiratory or cardiovascular diseases. The service is available for adults (18+) under a disclaimer and is not intended to replace a human physician.

According to IBM ( NYSE: IBM), “Watson Health unit is working directly with health organizations around the world to better understand the nature of COVID-19. The IBM Clinical Development system has been made available without charge to national health agencies to reduce the time and cost of clinical trials by providing data and analysis from web-enabled devices.”

“And our cognitive Operational Risk Insight tool has been made available to not-for-profit organizations, charged with information about the virus spread.”

IBM also reported, “US Department of Energy’s Oak Ridge National Laboratory (ORNL) has deployed the world’s most powerful and smartest supercomputer, IBM built Summit, in the fight against COVID-19.”

In a developer post, ‘AI Helps Doctors Diagnose the Coronavirus’, NVIDIA Corporation

(NASDAQ: NVDA) reported, “At the epicenter of the Coronavirus in Wuhan China, a team of physicians at the Zhongnan Hospital are using GPU-accelerated AI software to detect visual signs of the coronavirus (Covid 19).”

“Physicians there say the AI-based software, which relies on NVIDIA GPUs for both training and inference, has helped overworked staff screen patients and prioritize those likely to have the virus.”

“The software, developed by Beijing-based startup Infervision, a member of the NVIDIA Inception, NVIDIA’s startup accelerator program, can identify typical signs or partial signs of Covid 19 infection. To do this, Infervision’s software detects signs of pneumonia caused by the virus.”

“Once the outbreak began, the company quickly fine-tuned their existing pneumonia models to look more closely at coronavirus pneumonia.”

The White House, realizing how AI can play an integral role in finding solutions, issued a press release on March 16^th, ‘Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset’.

From the news – “Today, researchers and leaders from the Allen Institute for AI, Chan Zuckerberg Initiative (CZI), Georgetown University’s Center for Security and Emerging Technology (CSET), Microsoft (NASDAQ: MSFT) and the National Library of Medicine (NLM) at the National Institutes of Health released the ‘COVID-19 Open Research Dataset (CORD-19’) of scholarly literature about COVID-19, SARS-CoV-2, and the Coronavirus group.”

“Now, the White House joins these institutions in issuing a call to action to the Nation’s artificial intelligence experts to develop new text and data mining techniques that can help the science community answer high-priority scientific questions related to COVID-19.”

“The collection was constructed via a unique collaboration between Microsoft, NLM, CZI, and the Allen Institute for AI, coordinated by Georgetown University. Microsoft’s web-scale literature curation tools were used to identify and bring together worldwide scientific efforts and results, CZI provided access to pre-publication content, NLM provided access to literature content, and the Allen AI team transformed the content into machine-readable form, making the corpus ready.”

As the global race continues to track, manage and find solutions for the coronavirus, AI can move rapidly, analyze data, map and provide medical information and updates to the world as vaccines are being developed. AI is currently on a path to replace dogs as man’s best friend; at least for the short term.

To get current numbers by country on the Coronavirus visit: Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE)

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: GTCH is a paid monthly featured company for news and social media on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.aspLearn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

Monday, March 23, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 387 (CSE: $PLTH.C) (OTCQX: $PLNHF) (TSX: $VFF.TO) (NASDAQ: $VFF) (CSE: $IMCC.C)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 387 (CSE: $PLTH.C) (OTCQX: $PLNHF) (TSX: $VFF.TO) (NASDAQ: $VFF) (CSE: $IMCC.C)

Delta, Kelowna, BC, March 23, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/032320-StocksToWatch.mp3

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/03231PLTH-PLNHF-VFF-IMCC.asp

Hear Investor ideas cannabis potcast on iTunes

Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few company announcements.

But first, in recent ne ws, The Alberta Cannabis Council (ACC), a not-for-profit industry trade group serving the province’s cannabis industry stakeholders, shared a letter with the Canadian government calling for it to grant the same access to economic relief programs to the country’s cannabis industry.

The letter was signed by 74 industry members and calls for the “equal and fair access to significant support for all cannabis companies working to keep employees employed, including access to wage subsidies as announced on March 18, 2020 by the Prime Minister and Finance Minister.”

Additionally, the letter asks that federal agencies offer “equal and fair access to funding through federal agencies, EDC [Export Development Canada] or BDC [Business Development Bank of Canada] as other industries have for credit instruments. Presently, for example, BDC has indicated that the regulated cannabis sector can not access the $10B in stimulus funding, part of which is available through that crown corporation.”

John Carle, the executive director for the ACC, along with the letter’s signatories, writes “We are not asking for special treatment, but rather equitable treatment.”

The letter also highlights the recent, non-COVID-19 related challenges the industry has faced in recent months, including difficult access to investor capital and the loss of more than 2,000 jobs across the industry.

“We are asking that this industry, which has added a cumulative total of $8B to the Canadian GDP over the course of the last year, specifically and explicitly be included in all economic stimulus measures and provided the support that is being offered to every other Canadian business at this time,” the letter reads.

Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNHF) announced last Friday, March 20, 2020, that Nevada Gov. Steve Sisolak issued a declaration ordering all recreational and medical marijuana dispensaries to close their storefronts. Legal cannabis statewide will be available by delivery only. In response to overwhelming customer demand, Planet 13 has significantly expanded its delivery capabilities, moving from five to eight delivery vehicles, all of which are now running twenty-four hours a day, seven days a week. The Company expects to add an additional seven vehicles to its delivery fleet over the next several days. Planet 13 offers delivery to Las Vegas and all other municipalities in the greater Las Vegas Valley.

"We have one of the largest delivery platforms in Nevada and will be expanding it to ensure continuity of service to the greater Las Vegas Valley residents. As one of the few companies with an existing delivery program, we have a responsibility to our community to pick up the slack as other dispensaries close," said Larry Scheffler and Bob Groesbeck, Co-CEOs and Co-Founders of Planet 13.

Village Farms International, Inc. (TSX: VFF) (NASDAQ: VFF) announced that its majority-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received approval from Health Canada to operate the final components of its 65,000 square foot, state-of-the-art processing center located within the 1.1 million square foot Delta 3 greenhouse facility. The significantly expanded processing area will enable Pure Sunfarms to generate additional production cost efficiencies, further elevate the quality of its products, expand its product offerings and increase its processing throughput.

Health Canada's approval of the additional processing area permits Pure Sunfarms to begin operation of:

● 11 additional drying rooms utilizing advanced drying technology and processes to further enhance the quality of Pure Sunfarms product;

● 5 additional packaging rooms;

● 2 additional testing areas;

● 6 additional storage areas; and,

● 7 extraction rooms with equipment capable of processing 35,000 kilograms of biomass annually.

The expanded processing center has been designed to satisfy full European Union GMP compliance and certification requirements, which Pure Sunfarms is currently pursuing. The 65,000 square foot processing centre has capacity to serve both the Delta 3 and Delta 2 greenhouse facilities, with a combined production area of 2.2 million square feet, at full production.

"The approval of this additional processing space enables Pure Sunfarms to enhance our operations and quality processes to further support our commitment to providing our customers with high-quality products at a great price," said Mandesh Dosanjh, President and CEO, Pure Sunfarms. "Pure Sunfarms expects to begin to realize the benefits of this new space in the coming quarter, allowing us to build on our strong performance in the Canadian markets we serve."

"Pure Sunfarms' success is directly attributable to the decades of large-scale growing and operational experience contributed by Village Farms, low-cost production, efficient capital investment, disciplined cost management and the installation of a smart, highly talented and experienced leadership team," said Michael DeGiglio, CEO, Village Farms. "It is a business model that positions Pure Sunfarms to continue to be a leader in the Canadian cannabis sector for years to come. The expansion of this processing area significantly strengthens Pure Sunfarms' capabilities to produce high-quality products, supports its ongoing pursuit of even greater production efficiencies and sets the stage for the introduction of new product formats to build on its leading sales performance in dried cannabis products."

IM Cannabis Corp. (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, announced that Focus Medical Herbs Ltd., a licensed medical cannabis producer in Israel, has signed a 12-month definitive supply agreement with Intelicanna Ltd. (TASE:INTL) for a minimum of 500kg and up to 1,000kg of medical cannabis. Additional purchases may be made by Focus Medical under this agreement without a change to the contracted price paid to Intelicanna. The final products will be sold to pharmacies in Israel under the IMC brand.

Focus Medical is one of eight original licensed producers in Israel with over 10 years of experience growing high quality medical cannabis in the Israeli market. Focus Medical has an exclusive commercial agreement with IMC to distribute its production under the IMC brand. IMC's strategy in Israel is to pursue additional supply agreements of this nature in order to continue increasing market share of the IMC brand.

"The demand for medical cannabis in Israel is rising quickly and securing additional supply with a premium cultivator is an excellent long-term development for the IMC brand. This agreement also represents strong third-party validation of Focus Medical's intellectual property in plant genetics which are unique and favored by many Israeli consumers," says Oren Shuster, Chief Executive Officer of IMC. "IMC will continue to pursue similar arrangements with other medical cannabis suppliers as pharmacies in Israel demand more and more quality products for their patients over the long-term."

The Supply Agreement between Focus Medical and Intelicanna is for a term of 12 months from the date of the first planting in Intelicanna's facility. The Supply Agreement is contingent on Intelicanna receiving IMC-GAP approval by June 15, 2020.

Intelicanna will obtain access to Focus Medical's unique and proprietary genetics for the purpose of delivering product under the Supply Agreement but the genetics will remain the exclusive property of Focus Medical. Intelicanna may not sell, transfer or perform research with the genetics it accesses through this Supply Agreement without consent from Focus Medical. Under the Supply Agreement, Intelicanna is responsible for all production activities but Focus Medical will have access to Intelicanna's growing facility to monitor the entire growing process.

Focus Medical will make a deposit against future deliveries of 427,500 NIS (approximately CDN$170,000) within a month from the execution date of the Supply Agreement. The balance of payments for future deliveries will be made by Focus Medical within 30 days from delivery by Intelicanna.

Panaxia (TelAviv: PNAX), the largest manufacturer and distributor of pharmaceutical cannabis products in Israel, and its partner Ultra Health have announced the arrival in Israel of the first shipment of hemp extract, having been awarded a first-of-its-kind permit to export cannabis oil from the US to Israel.

This unique license was granted to the companies in light of their recent qualification to manufacture and distribute at their joint New Mexico (Bernalillo) facility, including hemp extracts of particularly low (<0 .3="" and="" at="" axiban.="" be="" been="" begun="" brand="" by="" cannabis="" cbd-rich="" companies="" concentrations.="" delivered="" designed="" distribute="" distributes="" extracts="" facility="" had="" have="" health="" in="" is="" israel="" it="" licensed="" manufacture="" manufacturing="" materials="" medicinal="" mexico="" month="" new="" o:p="" of="" operated="" panaxia="" premium="" products.="" products="" raw="" recently="" supplies="" thc="" the="" them="" this="" throughout="" to="" ultra="" under="" us.="" us="" used="" was="" while="" will="">

Panaxia aims to produce within a short period of time an inventory large enough to satisfy several months of demand of all Israeli patients requiring this care. The products are designated for the Israeli market only and may not be distributed outside of Israel. Panaxia's CBD-rich oil is targeted at specific group of patients that require a miniscule dose of THC (categories C20, C24) among whom is a large group of children suffering from epilepsy or autism spectrum disorder (ASD).

Dr. Dadi Segal, Panaxia CEO: "We are pleased to be able to extend care to our patients in Israeli who are in acute need of this kind of medicinal cannabis care. Panaxia's superb R&D capabilities combined with the added value of a high-quality strategic company such as Ultra Health prove themselves time and again, especially with regard to the high quality of the products and stringent regulatory compliance."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the

Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

#CryptoCorner: #Bitcoin Sees Spike, Coinbase Sees Record Volumes, NetCents (CSE: $NC.C) Completes Technical Integration of #Crypto Credit Card

#CryptoCorner: #Bitcoin Sees Spike, Coinbase Sees Record Volumes, NetCents (CSE: $NC.C) Completes Technical Integration of #Crypto Credit Card

Point Roberts, WA, Delta BC March 23, 2020 - Investorideas.com, a leader in crypto and blockchain investing news brings you today’s edition of the Crypto Corner podcast and commentary on what’s driving the cryptocurrency market.

Listen to today’s Crypto Corner Podcast:

https://www.investorideas.com/Audio/Podcasts/2020/032320-CryptoMarket.mp3

Read this in full at https://www.investorideas.com/news/2020/crypto-corner/03231Bitcoin-Coinbase-NetCents.asp

Get the Crypto Corner Podcast on iTunes

Bitcoin Sees Spike Following Fed Announcement, Coinbase Registers Record Volumes, NetCents Completes Technical Integration of Crypto Credit Card and IMF Discusses CBDC

Stocks discussed: (CSE:NC)

Bitcoin (BTC) did not see much movement over the weekend, but has just this morning spiked from just under a $5,800 trading price to a peak of about $6,300, according to data from CoinMarketCap. This comes after a statement from the Federal Reserve’s Board of Governors, announcing the central bank’s intention to use “its full range of tools to support households, businesses, and the U.S. economy overall in this challenging time.” Characterized widely as “unlimited QE,” the news triggered “a brief rally in stocks and corporate bonds,” according to a Bloomberg report this morning, but that fizzled soon after trading opened in New York. Similarly Bitcoin seems to have steadied at press time.

But regardless of trading price, Bitcoin, and crypto trading more generally, is registering serious volume. A report from CoinDesk indicates that popular San Francisco-based exchange Coinbase witnessed record site traffic and a surge in market volume over the last several days. According to the article, Coinbase “processed $2 billion in crypto last Thursday and Friday,” and citing data from Bitwise, “$394 million in volume over the past 24 hours.”

Crypto payments provider NetCents Technology Inc. (CSE:NC) has completed the technical integration of the NetCents Cryptocurrency Credit Card. Notably, the press release indicates that NetCents has “started the first merchant integration, which will enable merchants to allow their users to load their branded credit cards using cryptocurrency.” Clayton Moore, CEO of NetCents Technology, said:

“Since starting this process, our relationship with Visa has evolved and expanded. We look forward to working with Visa, evolving and driving these initiatives together. We consider it a privilege to support Visa in their effort to bring best-in-class products to the market. We hope to update you on these advancements in the near future.”

A recently-published speech by International Monetary Fund (IMF) Deputy Managing Director, Tao Zhang to the London School of Economics explored the pros and cons of central bank digital currencies (CBDCs). Among the pros highlighted by Zhang were an increased efficiency brought on by decreased costs, greater financial inclusion afforded by the lack of requirement of a bank account, lower barriers to entry for new firms, enhanced monetary policy and the ability to counter other digital or cryptocurrencies. Zhang went on to identify the increased responsibilities required of central banks to implement CBDCs and the risk of negatively affecting their reputation and trustworthiness. Zhang also explored the idea of a hybrid option called a synthetic CBDC (sCBDC), wherein the “private sector would issue coins fully backed with central bank reserves, under the supervision of the central bank.”

Sam Mowers, Investorideas

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

The Crypto Corner is part of the Investor Ideas Membership content

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Cryptocurrency Disclaimer

Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800-665-0411

Get more Bitcoin and Blockchain Investor ideas – news, articles, podcasts and stock directories

About Investorideas.com

About Investorideas.com - Big Investing Ideas Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer/disclosure

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas, Trading Ideas and Stocks to Watch

Tuesday, March 24, 2020

Special Edition #AIEye: How #ArtificialIntelligence ( #AI) is Tracking, Modeling and Providing Medical Info #Coronavirus (OTC: $GTCH) (NASDAQ: $NVDA) (NYSE: $IBM) (NASDAQ: $MSFT)

Monday, March 23, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 387 (CSE: $PLTH.C) (OTCQX: $PLNHF) (TSX: $VFF.TO) (NASDAQ: $VFF) (CSE: $IMCC.C)

#CryptoCorner: #Bitcoin Sees Spike, Coinbase Sees Record Volumes, NetCents (CSE: $NC.C) Completes Technical Integration of #Crypto Credit Card

Blog Archive

Links

Search This Blog